Hurricane Capital Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
ACA
KCM
Hurricane Capital Advisors's XFOR Position: Q4 2024 in Review
Hurricane Capital Advisors sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 10,637 shares — an estimated $214K sold.
Hurricane Capital Advisors first reported a position in XFOR in Q4 2023 and held it in 4 quarters. The position peaked at $676K in Q1 2024. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.
- Hurricane Capital Advisors reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Hurricane Capital Advisors sold 10,637 X4 Pharmaceuticals shares in Q4 2024, an estimated $214K.
- Hurricane Capital Advisors first reported a position in X4 Pharmaceuticals in Q4 2023 and held it in 4 quarters.
- Hurricane Capital Advisors's X4 Pharmaceuticals position peaked at $676K in Q1 2024.
- 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.
Based on Hurricane Capital Advisors's 13F filing for Q4 2024, filed 3 Nov 2026.